A phase II study of irinotecan (CPT-11) alternated with a weekly schedule of oxaliplatin (L-OHP), high-dose leucovorin (LV) and a 48-hour infusion 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer (MCRC)
European Journal of Cancer（2001）
Key words
phase ii study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined